Genprex (GNPX) executive Vaczy received 245,000 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Catherine M Vaczy (executive at Genprex Inc., GNPX) reported that they received 245,000 shares on Feb 18, 2023. After these transactions the filing shows 245,000 shares held directly.
- Reporting person
- Vaczy Catherine M
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 18, 2023 | Grant or award (A) | Common Stock1 | +245,000 | - | - | 245,000 direct |
Holdings before and after
- Common Stock: 0 to 245,000 direct
Footnotes from the filing
- 1. This award of Restricted Stock Units ( RSUs ) is granted under the Genprex, Inc. (the Company ) 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Vaczy report in this GNPX Form 4?
Catherine M Vaczy (executive at Genprex Inc., GNPX) reported that they received 245,000 shares on Feb 18, 2023. After these transactions the filing shows 245,000 shares held directly.
How many GNPX shares does Vaczy hold after this filing?
The filing shows 245,000 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for GNPX
Earlier insider filings at GNPX
- Feb 22, 2023SEC Form 4: Berger Mark Stanley was granted 245,000 shares
- Feb 22, 2023SEC Form 4: Kumar Hermant was granted 200,000 shares
- Feb 22, 2023SEC Form 4: Confer Ryan M. was granted 245,000 shares, increasing direct ownership by 129% to 435,499 units
- Feb 22, 2023SEC Form 4: Varner John Rodney was granted 625,000 shares, increasing direct ownership by 117% to 1,159,735 units
- Aug 1, 2022SEC Form 4: Confer Ryan M. exercised 116,973 shares at a strike of $0.01, increasing direct ownership by 159% to 190,499 units
Keep researching GNPX
- GNPX insider tradesEvery buy and sale reported by Genprex Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- GNPX financial statementsRevenue, profit, cash flow and balance sheet from Genprex Inc.'s SEC filings.
Quantisnow market dataNASDAQ
GNPX
Genprex Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for GNPX
Full GNPX profile on Quantisnow Follow GNPX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time